Eurofarma Laboratórios S.A. Stock

Stocks

EUFA3

BREUFAACNOR4

Market Closed - Sao Paulo			5-day change	1st Jan Change
- ^BRL	-.--%		-.--%	-

08-14	Eurofarma Laboratórios S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-15	Eurofarma Laboratórios S.A. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Latest news: Eurofarma Laboratórios S.A.

08-14	Eurofarma Laboratórios S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-15	Eurofarma Laboratórios S.A. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
03-26	Eurofarma Laboratórios S.A. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI
01-23	Bavarian Nordic A/S Signs Distribution Agreement with Eurofarma to Expand Access to Chikungunya Vaccine in Brazil	CI
12-10	Psivant Therapeutics, Inc. announced that it has received $47.5 million in funding from YK Bioventures, Samsara BioCapital LLC, Roivant Sciences Ltd., LSV Capital Management, LLC, Eurofarma Laboratórios S.A. and other investors	CI
11-14	Eurofarma Laboratórios S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
21/10/25	Mentis Care, Inc Appoints Hassan Kotob as Chief Executive Officer	CI
21/10/25	SK Biopharmaceuticals Co., Ltd. Launches Joint Venture with Eurofarma for Ai-Based Epilepsy Management Platform	CI
22/08/25	Eurofarma Laboratórios S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
16/05/25	Eurofarma Laboratórios S.A. Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
27/03/25	Eurofarma Laboratórios S.A. Reports Earnings Results for the Full Year Ended December 31, 2024	CI
17/03/25	Eurofarma Laboratórios S.A. acquired 60% stake in Klibra Agenciamento de Marcas e Negócios for approximately BRL 160 million.	CI
15/11/24	Eurofarma Laboratórios S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	CI

More news

Managers and Directors: Eurofarma Laboratórios S.A.

Manager	Title	Age	Since
Marco Billi CEO	Chief Executive Officer	-	23/11/2021
Alexandre Mendes Palhares IRC	Investor Relations Contact	40	23/11/2021

Director	Title	Age	Since
Maurízio Billi CHM	Chairman	-	23/11/2021
Cristina Presz Palmaka de Luca BRD	Director/Board Member	58	23/11/2021
Juliana Rozenbaum Munemori BRD	Director/Board Member	50	01/01/2019

More insiders

Latest insider transactions

Date	Insider	Type	Quantity	% Market Cap.
1/10/25 A	Controlling Shareholder Brazilian	Buy	1,644,236	0.1665%
12/4/24 A	Controlling Shareholder Brazilian	Sell	15,405,639	1.5600%
12/4/24 A	Controlling Shareholder Brazilian	Buy	15,405,639	1.5600%

Transaction History

Financials

	2024	2025
Net sales	10.97B 2.03B 1.82B 1.68B 1.52B 2.83B 193B 2.88B 19.99B 7.97B 101B 7.61B 7.45B 320B	12.48B 2.31B 2.07B 1.91B 1.72B 3.22B 220B 3.28B 22.73B 9.07B 115B 8.65B 8.47B 364B
Net income	117M 21.67M 19.41M 17.91M 16.2M 30.3M 2.06B 30.79M 214M 85.23M 1.08B 81.33M 79.6M 3.42B	571M 106M 94.58M 87.25M 78.96M 148M 10.05B 150M 1.04B 415M 5.26B 396M 388M 16.67B
Net Debt	-	-

Projected Income Statement - Annual - Eurofarma Laboratórios S.A.

* Estimated data More financial data

Company Profile

Employees

13,000

Sector

More about the company